Safety of Medicines - A Guide to Detecting and Reporting Adverse Drug Reactions - Why Health Professionals Need to Take Action
(2002; 16 pages)
Table des matières
Afficher le documentIntroduction
Afficher le documentGlossary
Afficher le documentThe magnitude of the problem
Afficher le documentWhy postmarketing surveillance and reporting ADR is needed
Afficher le documentWhy pharmacovigilance is needed in every country
Afficher le documentHow voluntary reporting on ADRs can prevent new medicine tragedies from developing
Afficher le documentHow voluntary reporting on ADRs can influence labelling
Afficher le documentWhy health professionals are in the best position to detect and report on ADRs
Afficher le documentHow to recognize ADRs
Afficher le documentWhat should be reported?
Afficher le documentHow to report ADRs?
Afficher le documentReferences
Afficher le documentAcknowledgements
 

Why health professionals are in the best position to detect and report on ADRs

The effectiveness of a national postmarketing surveillance programme is directly dependent on the active participation of health professionals. Health professionals are in the best position to report on suspected ADRs observed in their every day patient care.

All healthcare providers (physicians, pharmacists, nurses, dentists and others) should report ADRs as part of their professional responsibility, even if they are doubtful about the precise relationship with the given medication.

You can reduce the suffering and save thousands of patients lives by doing one thing:

Report suspected adverse drug reactions.

vers la section précédente vers la section suivante
 

Dernière mise à jour: le 3 mai 2013